- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics ; volume:10 ; number:2 ; day:12 ; month:4 ; year:2012 ; pages:1 ; date:12.2012
Hereditary cancer in clinical practice ; 10, Heft 2 (12.4.2012), 1, 12.2012
- Creator
-
Oakes, SR
- Contributor
-
Vaillant, F.
Lim, E.
Lee, L.
Breslin, K.
Feleppa, F.
Deb, S.
Ritchie, ME
Takano, E.
Ward, T.
Fox, SB
Generali, D.
Smyth, GK
Strasser, A.
Huang, DCS
Visvader, JE
Lindeman, GJ
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-10-S2-A25
- URN
-
urn:nbn:de:1111-2016073117786
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Oakes, SR
- Vaillant, F.
- Lim, E.
- Lee, L.
- Breslin, K.
- Feleppa, F.
- Deb, S.
- Ritchie, ME
- Takano, E.
- Ward, T.
- Fox, SB
- Generali, D.
- Smyth, GK
- Strasser, A.
- Huang, DCS
- Visvader, JE
- Lindeman, GJ
- SpringerLink (Online service)
Other Objects (12)
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
BH3-mimetics: recent developments in cancer therapy
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
BH3 mimetics for the treatment of prostate cancer
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
BH3-mimetics: recent developments in cancer therapy
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
BH3 mimetics for the treatment of prostate cancer
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
BH3-mimetics: recent developments in cancer therapy
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
BH3 mimetics for the treatment of prostate cancer
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia